The UK Competition and Markets Authority (CMA) has said that if Stryker Corp.’s purchase of Wright Medical Group NV went ahead, it would have a negative impact on patients in the UK who need ankle replacements. Following an initial investigation, the CMA found that the proposed merger would result in the combined company having a share of over 90% of the total ankle replacement prostheses market in the UK.
CMA senior director Joel Bamford said: “The CMA is concerned that this merger and the resulting reduction in competition could...